Literature DB >> 19614795

Obstructive sleep apnea is highly prevalent and correlates with impaired glycemic control in consecutive patients with the metabolic syndrome.

Luciano F Drager1, Eduardo L Queiroz, Heno F Lopes, Pedro R Genta, Eduardo M Krieger, Geraldo Lorenzi-Filho.   

Abstract

Obstructive sleep apnea (OSA) and the metabolic syndrome (MS) are independently associated with increased cardiovascular risk. The objective of the present study was to determine the prevalence of OSA among consecutive patients with MS and to determine whether OSA is associated with impaired glycemic control. Fifty consecutive patients with a recent diagnosis of MS and no previous diagnosis of OSA underwent a polysomnography and anthropometric and laboratory measurements. The prevalence of OSA (apnea-hypopnea index >or=15 events per hour of sleep) was 68% and in the same range of all other individual components of MS. Moreover, OSA was associated with increased levels of glucose (P=.03) and glycosylated hemoglobin (P=.03) but not with body mass index (P=.30). Glycosylated hemoglobin was independently associated with glucose (P<.001) and apnea-hypopnea index (P=.03). The prevalence of OSA is in the same range as all the individual components of MS and is independently associated with impaired glycemic control.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19614795     DOI: 10.1111/j.1559-4572.2008.00046.x

Source DB:  PubMed          Journal:  J Cardiometab Syndr        ISSN: 1559-4564


  7 in total

Review 1.  Obstructive Sleep Apnoea and Type 2 Diabetes.

Authors:  Abd A Tahrani; Asad Ali
Journal:  Eur Endocrinol       Date:  2014-02-28

2.  Consequences of comorbid sleep apnea in the metabolic syndrome--implications for cardiovascular risk.

Authors:  Ivani C Trombetta; Virend K Somers; Cristiane Maki-Nunes; Luciano F Drager; Edgar Toschi-Dias; Maria Janieire N N Alves; Raffael F Fraga; Maria Urbana P B Rondon; Maíta G Bechara; Geraldo Lorenzi-Filho; Carlos E Negrão
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

3.  The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome.

Authors:  Luciano F Drager; Heno F Lopes; Cristiane Maki-Nunes; Ivani C Trombetta; Edgar Toschi-Dias; Maria Janieire N N Alves; Raffael F Fraga; Jonathan C Jun; Carlos E Negrão; Eduardo M Krieger; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

4.  Identifying the risk of obstructive sleep apnea in metabolic syndrome patients: Diagnostic accuracy of the Berlin Questionnaire.

Authors:  Felipe X Cepeda; Leslie Virmondes; Sara Rodrigues; Akothirene C B Dutra-Marques; Edgar Toschi-Dias; Fernanda C Ferreira-Camargo; Maria Fernanda Hussid; Maria Urbana Pb Rondon; Maria Janieire N N Alves; Ivani C Trombetta
Journal:  PLoS One       Date:  2019-05-21       Impact factor: 3.240

5.  Association of Metabolic Syndrome With Prevalence of Obstructive Sleep Apnea and Remission After Sleeve Gastrectomy.

Authors:  Yufei Chen; Lijia Chen; Lingxia Ye; Jiabin Jin; Yingkai Sun; Ling Zhang; Shaoqian Zhao; Yifei Zhang; Weiqing Wang; Weiqiong Gu; Jie Hong
Journal:  Front Physiol       Date:  2021-03-31       Impact factor: 4.566

6.  The cardioprotective power of leaves.

Authors:  Dominika Dudzińska; Magdalena Boncler; Cezary Watala
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

7.  Exaggerated Exercise Blood Pressure as a Marker of Baroreflex Dysfunction in Normotensive Metabolic Syndrome Patients.

Authors:  Akothirene C Dutra-Marques; Sara Rodrigues; Felipe X Cepeda; Edgar Toschi-Dias; Eduardo Rondon; Jefferson C Carvalho; Maria Janieire N N Alves; Ana Maria F W Braga; Maria Urbana P B Rondon; Ivani C Trombetta
Journal:  Front Neurosci       Date:  2021-06-09       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.